Go back
HSA-MIR-101-1
| Id | 66 |
| Name | hsa-mir-101-1 |
| Chromosome | chr1 (NC_000001) |
| PrecStart | 65058434 |
| PrecEnd | 65058508 |
| Length | 75 |
| Strand | reverse |
| Is at most 5 Mbp to chromosome end | Yes |
| Is at most 5 Mbp to chromosome centromere | Yes |
| Protein host gene | JAK1 |
| Intronic | Yes |
| Clustered | Yes |
| Probability | 0.6296995608758366 |
| ChrEnd | 1 |
| ChrCentr | 1 |
DOI | Detected in | In presence of | Expression profile |
|---|---|---|---|
| https://doi.org/10.1038/s41598-017-05777-0 | Perge Pál, Butz Henriett, Pezzani Raffaele, Bancos Irina, Nagy Zoltán, Pálóczi Krisztina, Nyírő Gábor, Decmann Ábel, Pap Erna, Luconi Michaela, Mannelli Massimo, Buzás Edit I., Tóth Miklós, Boscaro Marco, Patócs Attila, Igaz Peter (2017). Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors. Scientific Reports, 7(1), . | adrenal cortical carcinoma | up |
| https://doi.org/10.3892/or.2016.4980 | Lv Xuecheng, Li Jinghua, Yang Bingnan (2016). Clinical effects of miR-101 on prognosis of hepatocellular carcinoma and carcinogenic mechanism of anti-miR-101. Oncology Reports, 36(4), 2184-2192. | hepatocellular carcinoma | up |
| https://doi.org/10.3892/mmr.2017.6139 | Xu Xiaochao, Liu Chao, Bao Jinku (2017). Hypoxia-induced hsa-miR-101 promotes glycolysis by targeting TIGAR mRNA in clear cell renal cell carcinoma. Molecular Medicine Reports, 15(3), 1373-1378. | renal clear cell carcinoma | up |
| https://doi.org/10.1038/s41598-017-05777-0 | Perge Pál, Butz Henriett, Pezzani Raffaele, Bancos Irina, Nagy Zoltán, Pálóczi Krisztina, Nyírő Gábor, Decmann Ábel, Pap Erna, Luconi Michaela, Mannelli Massimo, Buzás Edit I., Tóth Miklós, Boscaro Marco, Patócs Attila, Igaz Peter (2017). Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors. Scientific Reports, 7(1), . | adrenal cortical carciFalsema | up |
| https://doi.org/10.1159/000488456 | Pollard Jennifer, Burns Phil A., Hughes Tom A., Ho-Yen Colan, Jones J. Louise, Mukherjee Geetashree, Omoniyi-Esan Ganiat O., Titloye Nicholas Akinwale, Speirs Valerie, Shaaban Abeer M. (2018). Differential Expression of MicroRNAs in Breast Cancers from Four Different Ethnicities. Pathobiology, 85(4), 220-226. | breast cancer | up |
| https://doi.org/10.3892/ol.2013.1251 | LIU SHANG-GUO, QIN XIU-GUANG, ZHAO BAO-SHENG, QI BO, YAO WEN-JIAN, WANG TIAN-YUN, LI HAN-CHEN, WU XIANG-NAN (2013). Differential expression of miRNAs in esophageal cancer tissue. Oncology Letters, 5(5), 1639-1642. | esophageal cancer | up |
| https://doi.org/10.3892/or.2016.4980 | Lv Xuecheng, Li Jinghua, Yang Bingnan (2016). Clinical effects of miR-101 on prognosis of hepatocellular carcinoma and carcinogenic mechanism of anti-miR-101. Oncology Reports, 36(4), 2184-2192. | hepatocellular carciFalsema | up |
| https://doi.org/10.1590/1678-4685-gmb-2016-0334 | Tantawy Marwa, Elzayat Mariam G., Yehia Dina, Taha Hala (2018). Identification of microRNA signature in different pediatric brain tumors. Genetics and Molecular Biology, 41(1), 27-34. | medulloblastoma | up |
| https://doi.org/10.3892/mmr.2017.6139 | Xu Xiaochao, Liu Chao, Bao Jinku (2017). Hypoxia-induced hsa-miR-101 promotes glycolysis by targeting TIGAR mRNA in clear cell renal cell carcinoma. Molecular Medicine Reports, 15(3), 1373-1378. | renal clear cell carciFalsema | up |